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Background
Cardiovascular Magnetic Resonance (CMR) by late gadoli-
nium enhancement (LGE) allows to detect myocardial
fibrosis. Myocardial fibrosis was shown to be a relative
common finding in large cohort of Italian thalassemia
major (TM) patients mainly related to HCV infection, but
specific studies involving only pediatric patients are not
available. Our aim was to investigate the prevalence and
clinical-instrumental correlates of myocardial fibrosis in
pediatric TM patients.
Methods
We studied retrospectively 76 pediatric patients with TM
(44 boys, 4.2 -17.9 years old, mean age 13.6 ± 3.4 years)
enrolled in the MIOT (Myocardial Iron Overload in
Thalassemia) Network. All patients were well transfused
and chelated since the early childhood.LGE images were
acquired to detect myocardial fibrosis. Myocardial iron
overload (MIO) was measured by T2* multislice multiecho
technique. Biventricular function parameters were quanti-
tatively evaluated by cine images.
Results
Myocardial fibrosis was detected in 12 (15.8%) patients. In
all patients the location of the fibrosis was epi-mesocardial,
with no ischemic pattern. The youngest patient showing
myocardial fibrosis had 13 years of age. Table 1 shows the
comparison between patients with and without myocardial
fibrosis. A significant higher MIO was detected in patients
with myocardial fibrosis. The left atrial area, all the left
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Sex (M/F) 10/2 34/30 0.062
Age (years) 15.4 ± 1.8 13.3 ± 3.5 0.073
Transfusions starting age (years) 1.2 ± 0.9 1.3 ± 0.8 0.691
Chelation starting age (years) 3.1 ± 1.8 3.1 ± 2.3 0.705
HCV antibodies, N (%) 0 3 (4.8%) 0.437
Hb pre-transfusion (g/dl) 9.7 ± 0.3 9.5 ± 0.7 0.757
Ferritin levels (ng/l) 3012 ± 2167 2225 ± 1396 0.226
ALT (u/l) 41.6 ± 12.5 38.6 ± 32.6 0.268
AST (u/l) 46.6 ± 41.2 33.4 ± 25.9 0.207
Global Heart T2* (ms) 20.9 ± 13.9 30.6 ± 9.7 0.022
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ventricular (LV) indexed volumes, the LV mass index and
the bi-ventricular stroke volume indexes were significantly
higher in the fibrosis group than in the no-fibrosis group.
Conclusions
In pediatric TM patients myocardial fibrosis is not a rare
finding to keep in mind in the cardiological management.
When appropriate treatment has been administered since
early childhood, CMR LGE can be postponed until 13
years of age. By the natural history of this large cohort of
pediatric patients where HCV infection has been appropri-
ately prevented, myocardial fibrosis seem to be associated
with MIO and high cardiac output.
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Table 1 Clinical and instrumental correlates in the fibrosis and no-fibrosis group. (Continued)
MRI CIC (mg/g dry weight) 2.0 ± 1.7 0.8 ± 0.6 0.022
Patients with global heart T2* < 20 ms, N (%) 7 (58.3) 12 (18.8) 0.008
N. of seg. with abnormal T2* 9.0 ± 7.0 3.8 ± 5.2 0.030
Left atrial area (cm2) 18.3 ± 3.1 15.9 ± 3.9 0.050
Right atrial area (cm2) 16.9 ± 4.3 14.9 ± 3.5 0.169
Left ventricular end-diastolic volume index (ml/m2) 102.9 ± 23.5 87.0 ± 16.3 0.005
Left ventricular end-systolic volume index (ml/m2) 42.0 ± 12.1 35.1 ± 8.9 0.022
Left ventricular stroke volume index (ml/m2) 60.7 ± 12.4 51.8 ± 10.7 0.012
Left ventricular mass index (g/m2) 65.3 ± 11.4 53.8 ± 11.4 0.003
Left ventricular ejection fraction (%) 59.2 ± 4.4 59.7 ± 5.9 0.368
Right ventricular end-diastolic volume index (ml/m2) 96.9 ± 25.6 81.6 ± 17.1 0.089
Right ventricular end-systolic volume index (ml/m2) 36.9 ± 13.7 32.3 ± 8.3 0.458
Right ventricular stroke volume index (ml/m2) 61.5 ± 11.6 48.9 ± 14.1 0.005
Right ventricular ejection fraction (%) 62.6 ± 4.4 60.2 ± 7.1 0.175
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